PrevPac (Prevacid, Amoxicillin, Clarithromycin)
Phase 2Small molecule
PrevPac (Prevacid, Amoxicillin, Clarithromycin) is one of 13 small molecule programs targeting Pseudomyxoma Peritonei. It is currently in Phase 2.
1
Indications
1
Total Trials
1
Active Trials
12
Competitors
Pipeline
Status by Indication[3][1]
Indication
Competition
Competitive Landscape
13 competitors in Pseudomyxoma Peritonei
#DrugCompanyPhaseTrials
1Cytoxan
BBaxter Healthcare Corporation
Approved
Mitosol
UUroGen Pharma Ltd.
Approved
Xeloda
EEngelhard Arzneimittel GmbH & Co.KG
Phase 2
Acetadote
AArbor Pharmaceuticals, Inc.
Phase 2
FOLFOX
AstraZenecaPhase 2
Cryoprecipitate
CSL BehringPhase 3
Beyfortus
BeiGenePhase 1
Cysteine Hydrochloride
NovartisPhase 1
Intraperitoneal 5FU
WWashington University School of Medicine
Phase 2
Bromelain
IIndiana University
Phase 2
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Clinical
Trials by Indication[1]
Sources
References
- [1]
- [2]
- [3]
- [4]
Details
Drug Info
Quick Facts
- Modality
- Small molecule[2]
- Highest Phase
- Phase 2[1]
- Company
- MMercy Medical Center